CLINICAL_TRIALS
trial_result
· 2015-10-06
Clinical Trial Update: Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Summary
A Phase 2 trial evaluating sorafenib in elderly patients with metastatic renal cell carcinoma, with the study subsequently terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centro di Riferimento Oncologico - Aviano | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: TERMINATED